Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
29 January 2010
IN THIS ISSUE
H1N1 pandemic hearing
European generics plan
Nanotechnology safety act
EMA priorities
More...
:: BANNER AD HERE ::
 
EMA outlines priorities for 2010–2015
The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years. More...
  :: IMAGE ::
 
EMA outlines priorities for 2010–2015
The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years. More...
  :: IMAGE ::
 
EMA outlines priorities for 2010–2015
The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years. More...
  :: IMAGE ::
 
EMA outlines priorities for 2010–2015
The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years. More...
  :: IMAGE ::
 
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile
Veltek
Peter Soelkner
Managing Director, Vetter Pharma International GmbH

Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc. Read more...

Podcast
Veltek
Peter Soelkner
Managing Director, Vetter Pharma International GmbH

Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc. Read more...

Key Topic Updates
Latest blog posts
Warning: this blog can seriously improve your health!
Warning: this blog can seriously improve your health!
Warning: this blog can seriously improve your health!

February events
Warning: this blog can seriously improve your health!
Warning: this blog can seriously improve your health!
Warning: this blog can seriously improve your health!

Latest articles
Warning: this blog can seriously improve your health!
Warning: this blog can seriously improve your health!
Warning: this blog can seriously improve your health!

Key Topic Updates

 
Survey
When do you think the pharmaceutical industry will experience an economic recovery?
  Sometime in 2010 44%
  Not until 2011 or later
56%

This week we would like to know...

Do you think lyophilisation is time consuming, wasteful in energy consumption and very expensive in hardware?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.